We serve Chemical Name:biphenyl-2,2′,3-triol CAS:91368-55-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:biphenyl-2,2′,3-triol
CAS.NO:91368-55-7
Synonyms:3-(2-hydroxyphenyl)benzene-1,2-diol;c0040;2,3,2′-trihydroxybiphenyl;3-(2-Hydroxyphenyl)catechol;3-Hpcc;[1,1′-biphenyl]-2,2′,3-triol;2,2′,3-Biphenyltriol;2,2′,3-Trihydroxybiphenyl
Molecular Formula:C12H10O3
Molecular Weight:202.20600
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:388.8ºC at 760mmHg
Density:1.347g/cm3
Index of Refraction:
PSA:60.69000
Exact Mass:202.06300
LogP:2.47040
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-(2-hydroxyphenyl)benzene-1,2-diol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,2′,3-Trihydroxybiphenyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(2-hydroxyphenyl)benzene-1,2-diol Use and application,3-(2-Hydroxyphenyl)catechol technical grade,usp/ep/jp grade.
Related News: Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely. biphenyl-2,2′,3-triol manufacturer In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum. biphenyl-2,2′,3-triol supplier Rates of breast cancer-related genetic mutations in Black and white women are the same, according to a new study that contradicts previous research. biphenyl-2,2′,3-triol vendor Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely. biphenyl-2,2′,3-triol factory In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.
